tert-butyl 4-(5-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4,6-trioxohexahydro-5-pyrimidinyl)-1-piperazinecarboxylate | 556052-18-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: tert-butyl 4-(5-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4,6-trioxohexahydro-5-pyrimidinyl)-1-piperazinecarboxylate
• 英文别名: 4-{5-[4-(2-Methyl-quinolin-4-ylmethoxy)-phenyl]-2,4,6-trioxo-hexahydro-pyrimidin-5-yl}-piperazine-1-carboxylic acid tert-butyl ester；tert-butyl 4-[5-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]-2,4,6-trioxo-1,3-diazinan-5-yl]piperazine-1-carboxylate
• CAS: 556052-18-7
• 化学式: C₃₀H₃₃N₅O₆
• 分子量: 559.622
• InChiKey: MUEJBYPIDLKGKN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  41
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  130
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  tert-butyl 4-(5-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4,6-trioxohexahydro-5-pyrimidinyl)-1-piperazinecarboxylate 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 以100%的产率得到5-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-5-(1-piperazinyl)-2,4,6(1H, 3H, 5H)-pyrimidinetrione
  参考文献：
  名称：

  Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-α converting enzyme

  摘要：

  New inhibitors of tumor necrosis factor-a converting enzyme (TACE) were discovered with a pyrimidine-2,4,6-trione in place of the commonly used hydroxamic acid. These non-hydroxamate TACE inhibitors were developed by incorporating a 4-(2methyl-4-quinolinylmethoxy)phenyl group, an optimized TACE selective P1' group. Several leads were identified with IC50 values around 100 nM in a porcine TACE assay and selective over MMP-1, -2, -9, -13, and aggrecanase. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.04.039
• 作为产物：
  描述：

  4-羟基苯乙酸甲酯 在 sodium methylate 、 sodium hydride 、 caesium carbonate 作用下， 以 四氢呋喃 、 甲醇 、 二甲基亚砜 为溶剂， 生成 tert-butyl 4-(5-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4,6-trioxohexahydro-5-pyrimidinyl)-1-piperazinecarboxylate
  参考文献：
  名称：

  Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-α converting enzyme

  摘要：

  New inhibitors of tumor necrosis factor-a converting enzyme (TACE) were discovered with a pyrimidine-2,4,6-trione in place of the commonly used hydroxamic acid. These non-hydroxamate TACE inhibitors were developed by incorporating a 4-(2methyl-4-quinolinylmethoxy)phenyl group, an optimized TACE selective P1' group. Several leads were identified with IC50 values around 100 nM in a porcine TACE assay and selective over MMP-1, -2, -9, -13, and aggrecanase. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.04.039

文献信息

• Barbituric acid derivatives as inhibitors of TNF-alpha converting enzyme (TACE) and/or matrix metalloproteinases
  申请人：——

  公开号：US20030166647A1

  公开（公告）日：2003-09-04

  The present application describes novel barbituric acid derivatives of formula I: 1 or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, B, L, R 1 , W, Z, U a , X a , Y a , and Z a are defined in the present specification, which are useful as TNF-&agr; converting enzyme (TACE) and matrix metalloproteinses (MMP) inhibitors.

  本申请描述了式I的新型巴比妥酸衍生物：1或其药用可接受的盐或前药形式，其中A、B、L、R1、W、Z、Ua、Xa、Ya和Za如本规范中定义，这些衍生物可用作TNF-α转化酶（TACE）和基质金属蛋白酶（MMP）抑制剂。
• [EN] BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF- DOLLAR G(A) CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES<br/>[FR] DERIVES D'ACIDE BARBITURIQUE UTILISES COMME INHIBITEURS DE L'ENZYME DE CONVERSION DU TNF- DOLLAR G(A) (TACE) ET/OU DE METALLOPROTEINASES MATRICIELLES
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2003053940A1

  公开（公告）日：2003-07-03

  The present application describes novel barbituric acid derivatives of formula (I), or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, B, L, R1, W, Z, U?a, Xa, Ya, and Za¿ are defined in the present specification, which are useful as TNF-α converting enzyme (TACE) and matrix metalloproteinases (MMP) inhibitors.

  本申请描述了新的巴比妥酸衍生物的公式（I），或其药学上可接受的盐或前药形式，其中A、B、L、R1、W、Z、Ua、Xa、Ya和Za在本说明中有定义，它们可用作TNF-α转化酶（TACE）和基质金属蛋白酶（MMP）抑制剂。
• US6936620B2
  申请人：——

  公开号：US6936620B2

  公开（公告）日：2005-08-30